Slovakia CBD status in 2026: legal access is not full product compliance
Slovakia removed cannabidiol from its national narcotics list with effect from 1 May 2021, but this did not create a blanket exemption from EU product rules. For ingestible…
News · Europe CBD
Poland's industrial hemp threshold sits at 0.3% THC, so shops often imply oils are clear. Ingestible CBD still needs EU novel food authorisation that does not exist. Sanepid can withdraw supplements that fail that test.

Poland’s 2022 Drug Prevention Act amendment raised the industrial hemp ceiling to 0.3% THC, aligning cultivation with the EU CAP field limit. Pure CBD is not listed as a narcotic. That agricultural line is real – and incomplete.
Finished oils, gummies and drinks sold for oral use sit under Regulation (EU) 2015/2283 on novel foods. No CBD extract or isolate has a full Commission authorisation for food use. Poland’s Glowny Inspektorat Sanitarny (Sanepid) has challenged and seized ingestible CBD products when paperwork or novel food status failed, even when THC sat under 0.3%.
EFSA’s provisional safe intake for high-purity CBD (about 2 mg/day for a 70 kg adult, February 2026) is a risk-assessment reference, not a Polish retail approval.
Shops lead with “under 0.3% THC” because that is the number buyers remember from German and Polish hemp headlines. The harder question is category: food, cosmetic, or medicine. In Poland, food is the layer that still blocks clean retail for oral CBD.
Disclaimer: News context for shoppers, not legal or medical advice. Sanepid practice can change. Check current official guidance before you buy, ship or sell CBD in Poland.
It helps classify industrial hemp, but ingestible CBD still needs EU novel food authorisation that has not been granted. Sanepid can challenge food supplements regardless of the THC line.
They can be under EU cosmetics rules with CPNP notification, permitted ingredients and no medical claims. That is a different track from food supplements.
No. EFSA's provisional intake is a risk-assessment reference for high-purity CBD, not a novel food authorisation.
Medical Disclaimer
The information on this website is for general informational purposes only and does not constitute medical advice. CBD products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before using CBD, especially if you are pregnant, nursing, taking medication, or have a medical condition.
CBD legality varies by country and region. In the EU, CBD products containing less than 0.2% THC are generally permitted, but local laws may differ. Verify the legal status in your jurisdiction before purchasing or using CBD products.
This website may contain affiliate links. We may earn a commission from qualifying purchases at no additional cost to you. Affiliate relationships do not influence our editorial content or product recommendations.
Last updated: August 2026